BusinessHorizon Pharma plc Presents Results from an Open-Label Study on the Use of PROCYSBI® (cysteamine bitartrate) Delayed-Release Capsules in Treatment-Naïve Children Younger than 6 Years of AgeBy Nasdaq OMXNov 4, 2017, 3:00 PM UTC
BusinessHorizon Pharma plc Announces Poster Presentation on KRYSTEXXA® (pegloticase injection) at the American Society of Nephrology Kidney Week 2017By Nasdaq OMXNov 3, 2017, 3:00 PM UTC
BusinessUPDATE -- Clinipace Worldwide Executive Joins Board of Kidney Health InitiativeBy Nasdaq OMXOct 27, 2017, 1:42 PM UTC
BusinessClinipace Worldwide Executive Joins Board of Kidney Health InitiativeBy Nasdaq OMXOct 27, 2017, 12:38 PM UTC
BusinessSatellite Healthcare Awards $800,000 in Applied Pragmatic Clinical Research GrantsBy Nasdaq OMXOct 4, 2017, 7:43 PM UTC
Business2017 Satellite Healthcare Norman S. Coplon Extramural Grant Program Now Accepting ApplicationsBy Nasdaq OMXJan 3, 2017, 2:00 PM UTC
BusinessCMS Five-Star Quality Rating System Identifies Satellite Healthcare as Leading 10 Largest Dialysis Providers in Percentage of Top-Rated Dialysis CentersBy Nasdaq OMXOct 27, 2016, 7:31 PM UTC
